Category
Aging
-
Aside from Eli Lilly’s drug, what else is in the Alzheimer’s pipeline?
Eli Lilly recently announced that the FDA had granted a breakthrough therapy designation for donanemab, its investigational antibody therapy for…
-
New tip sheet looks at a key cause of heart problems
While deaths from COVID-19 have naturally been a major focus over the past 18 months, cardiovascular disease (CVD) remains a…
-
Recent studies examine Rx medication use and fall risk in older adults
Falls are the leading cause of injury and death in older adults. Those with cognitive impairment are two to three…
-
Alzheimer’s drug approved Monday by FDA raises questions for journalists
Part two of two parts; the first ran Thursday, June 10. There’s still a great deal we don’t yet understand…
-
FDA approves new Alzheimer’s drug, but controversy persists
Part one of two parts; the second runs tomorrow, Friday, June 11. You might think that the first new drug…
-
New report details growth shifting ethnic, racial makeup of older adults
One in seven Americans is now 65 or older, comprising an increasing share of the U.S. population, according to the…
-
Report rates health of America’s seniors
The latest annual report on America’s seniors finds older adults showed improvement on clinical measures like access to quality health…
-
COVID-19 lockdown yielded positive benefits for some older adults, study suggests
An interesting study out of the UK found that the COVID-19 lockdown was a catalyst for many older people to…
-
Learn how to track vaccination rates among multigenerational households
In a deep-dive story for the Center for Public Integrity, a reporting team looked at the risk of contracting the…
-
All-star conference panel ponders aging’s future
For most of humankind’s existence, the average life expectancy was around 18 years. It’s only in the past century that…